Salvage Therapy Including Foscarnet and Ibalizumab for Multidrug Resistant HIV-2 Infection

被引:1
作者
Bachelard, Antoine [1 ,9 ]
Le Hingrat, Quentin [2 ,3 ]
Ferre, Valentine-Marie [2 ,3 ]
Le, Minh [4 ]
Peytavin, Gilles [3 ,4 ]
Damond, Florence [3 ]
Charpentier, Charlotte [3 ]
Goudot, Guillemette Fremont [5 ]
de Bouille, Jeanne Goupil [6 ]
Lariven, Sylvie [1 ]
Delobel, Pierre [7 ,8 ]
Yazdanpanah, Yazdan [1 ,3 ]
Descamps, Diane [2 ,3 ]
Matheron, Sophie [3 ]
Ghosn, Jade [1 ,3 ,9 ]
机构
[1] Hop Univ Paris Nord Val Seine, Assistance Publ Hop Paris Nord, Serv Malad Infect & Trop, Site Bichat Claude Bernard, Paris, France
[2] Hop Univ Paris Nord Val Seine, Assistance Publ Hop Paris Nord, Serv Virol, Site Bichat Claude Bernard, Paris, France
[3] Univ Paris Cite, IAME, INSERM UMRS1137, Paris, France
[4] Hop Univ Paris Nord Val Seine, Assistance Publ Hop Paris Nord, Serv Pharmacol, Site Bichat Claude Bernard, Paris, France
[5] CHI Andre Gregoire, Serv Malad Infect, Montreuil, France
[6] Hop Univ Paris Seine St Denis, Assistance Publ Hop Paris, Serv Malad Infect & Trop, Site Avicennes, Bobigny, France
[7] Ctr Hosp Univ Toulouse, Serv Malad Infect & Trop, Toulouse, France
[8] Univ Toulouse III, INSERM UMR1291 CNRS UMR5051, Toulouse, France
[9] Hop Xavier Bichat, Dept Infect Dis, 46 Rue Henri Huchard, F-75018 Paris, France
关键词
HIV-2; salvage therapy; ibalizumab; multi-drug resistance; foscarnet; MONOCLONAL-ANTIBODY; GROUP-A;
D O I
10.1093/cid/ciad695
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We evaluated Ibalizumab (IBA)-containing standardized optimized salvage regimen (with or without a 4-week foscarnet induction) in individuals harboring multidrug-resistant human immunodeficiency virus type 2 (HIV-2). Nine were included; 2 achieved virological suppression after foscarnet induction with a sustained suppression at Week 24 after IBA initiation, and an additional individual at Week 24 after Ibalizumab initiation.
引用
收藏
页码:1005 / 1010
页数:6
相关论文
共 11 条
[1]   New Sensitive One-Step Real-Time Duplex PCR Method for Group A and B HIV-2 RNA Load [J].
Avettand-Fenoel, Veronique ;
Damond, Florence ;
Gueudin, Marie ;
Matheron, Sophie ;
Melard, Adeline ;
Collin, Gilles ;
Descamps, Diane ;
Chaix, Marie-Laure ;
Rouzioux, Christine ;
Plantier, Jean-Christophe .
JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (08) :3017-3022
[2]  
BURKLY LC, 1992, J IMMUNOL, V149, P1779
[3]   Achieving virological control in pan-resistant HIV-1 infection: A case series [J].
Canetti, Diana ;
Muccini, Camilla ;
Spagnuolo, Vincenzo ;
Galli, Laura ;
Poli, Andrea ;
Gianotti, Nicola ;
Feasi, Marcello ;
Castagna, Antonella .
EBIOMEDICINE, 2022, 77
[4]   Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1 [J].
Emu, Brinda ;
Fessel, Jeffrey ;
Schrader, Shannon ;
Kumar, Princy ;
Richmond, Gary ;
Win, Sandra ;
Weinheimer, Steven ;
Marsolais, Christian ;
Lewis, Stanley .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (07) :645-654
[5]   Safety, Pharmacokinetics, and Antiretroviral Activity of Multiple Doses of Ibalizumab (formerly TNX-355), an Anti-CD4 Monoclonal Antibody, in Human Immunodeficiency Virus Type 1-Infected Adults [J].
Jacobson, Jeffrey M. ;
Kuritzkes, Daniel R. ;
Godofsky, Eliot ;
DeJesus, Edwin ;
Larson, Jeffrey A. ;
Weinheimer, Steven P. ;
Lewis, Stanley T. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (02) :450-457
[6]   Ibalizumab shows in-vitro activity against group A and group B HIV-2 clinical isolates [J].
Le Hingrat, Quentin ;
Collin, Gilles ;
Bachelard, Antoine ;
Ghosn, Jade ;
Chalal, Solayah ;
Pacanowski, Jerome ;
Peytavin, Gilles ;
Weinheimer, Steven ;
Marsolais, Christian ;
Damond, Florence ;
Matheron, Sophie ;
Charpentier, Charlotte ;
Descamps, Diane .
AIDS, 2022, 36 (08) :1055-1060
[7]   A New Mechanism of Resistance of Human Immunodeficiency Virus Type 2 to Integrase Inhibitors: A 5-Amino-Acid Insertion in the Integrase C-Terminal Domain [J].
Le Hingrat, Quentin ;
Collin, Gilles ;
Le, Minh ;
Peytavin, Gilles ;
Visseaux, Benoit ;
Bertine, Melanie ;
Tubiana, Roland ;
Karmochkine, Marina ;
Valin, Nadia ;
Collin, Fideline ;
Lemaignen, Adrien ;
Bernard, Louis ;
Damond, Florence ;
Matheron, Sophie ;
Descamps, Diane ;
Charpentier, Charlotte ;
Meyohas, Pr ;
Salmon, Pr ;
Pialoux, Pr ;
Matheron, Pr ;
Tubiana, Dr ;
De Truchis, Dr ;
Khuong-Josses ;
Goujard, Pr ;
Gerard, Dr ;
Mortier, Dr ;
Welker, Dr ;
Daneluzzi, Dr ;
Genet, Dr ;
Lepretre, Dr ;
Zucman, Dr ;
Force, Dr ;
Coutellier-Simon, Dr ;
Deleuze, Dr ;
Weiss, Pr ;
Garrait, Dr ;
Colin, Dr Masson ;
Lelievre, Pr ;
Blum, Dr ;
Dulioust, Dr ;
Perrone, Dr ;
Winter, Dr ;
La Torre, Dr ;
Molina, Pr ;
Devidas, Dr ;
Brunet, Dr ;
Rouveix, Pr ;
Kernbaum, Dr ;
Duvivier, Dr ;
Bouldouyre, Dr .
CLINICAL INFECTIOUS DISEASES, 2019, 69 (04) :657-667
[8]   Long-term Experience and Outcomes of Programmatic Antiretroviral Therapy for Human Immunodeficiency Virus Type 2 Infection in Senegal, West Africa [J].
Raugi, Dana N. ;
Ba, Selly ;
Cisse, Ousseynou ;
Diallo, Khardiata ;
Tamba, Ibrahima Tito ;
Ndour, Cheikh ;
Badiane, Ndeye Mery Dia ;
Fortes, Louise ;
Diallo, Mouhamadou Baila ;
Faye, Dominique ;
Smith, Robert A. ;
Sall, Fatima ;
Toure, Macoumba ;
Sall, ElHadji Ibrahima ;
Agne, Habibatou Diallo ;
Faye, Khadim ;
Diatta, Jean Philippe ;
Sy, Marie Pierre ;
Chang, Ming ;
Diaw, Binetou ;
Sambou, Jacques ;
Bakhoum, Raphael ;
Sy, Mame Demba ;
Niang, Alassane ;
Malomar, Jean Jacques ;
Coombs, Robert W. ;
Hawes, Stephen E. ;
Ndoye, Ibra ;
Kiviat, Nancy B. ;
Sow, Papa Salif ;
Seydi, Moussa ;
Gottlieb, Geoffrey S. .
CLINICAL INFECTIOUS DISEASES, 2021, 72 (03) :369-378
[9]   Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection [J].
Samri, Assia ;
Charpentier, Charlotte ;
Diallo, Mariama Sadjo ;
Bertine, Melanie ;
Even, Sophie ;
Morin, Veronique ;
Oudin, Anne ;
Parizot, Christophe ;
Collin, Gilles ;
Hosmalin, Anne ;
Cheynier, Remi ;
Thiebaut, Rodolphe ;
Matheron, Sophie ;
Collin, Fideline ;
Zoorob, Rima ;
Brun-Vezinet, Francoise ;
Autran, Brigitte ;
Appay, Victor ;
Chaghil, Nathalie ;
Charpentier, Charlotte ;
Descamps, Diane ;
Hosmalin, Anne ;
Pancino, Gianfranco ;
Manel, Nicolas ;
Marchand, Lucie ;
Matheron, Sophie ;
Collin, Fideline ;
Pedroza-Martins, Livia ;
Saez-Cirion, Asier ;
Samri, Assia ;
Thiebaut, Rodolphe ;
Vieillard, Vincent .
PLOS PATHOGENS, 2019, 15 (05)
[10]   Loss of Asparagine-Linked Glycosylation Sites in Variable Region 5 of Human Immunodeficiency Virus Type 1 Envelope Is Associated with Resistance to CD4 Antibody Ibalizumab [J].
Toma, Jonathan ;
Weinheimer, Steven P. ;
Stawiski, Eric ;
Whitcomb, Jeannette M. ;
Lewis, Stanley T. ;
Petropoulos, Christos J. ;
Huang, Wei .
JOURNAL OF VIROLOGY, 2011, 85 (08) :3872-3880